BREAKING! America Finally Revokes Emergency Use Status Of Hydroxychloroquine and Chloroquine For COVID-19 Treatment
Source: Hydroxychloroquine And Chloroquine Jun 16, 2020 3 years, 10 months, 1 week, 1 day, 22 hours, 42 minutes ago
Hydroxychloroquine: U.S. regulators finally on Monday revoked emergency authorization for malaria drugs hydroxychloroquine and chloroquine promoted by scammers for treating COVID-19 amid evidence these drugs do not work and are in fact lethal in certain cases and causes serious side effects.
.jpg)
Strangely the official revocation of the drug to treat COVID-19 was done on a very low profile with very little media coverage.
The US Food and Drug Administration said the drugs hydroxychloroquine and chloroquine are unlikely to be effective in treating the coronavirus. Citing reports of heart complications, the FDA said the drugs' unproven benefits "do not outweigh the known and potential risks."
Both drugs were that are also prescribed for lupus and rheumatoid arthritis, can cause heart rhythm problems, severely low blood pressure and muscle or nerve damage.
The new regulatory move means that shipments of the drugs obtained by the federal government will no longer be distributed to state and local health authorities for use against the coronavirus. The drugs are still available for alternate uses, so U.S. doctors could still prescribe them for COVID-19 ie a practice known as off-label prescribing.
A Cleveland Clinic researcher who has been a frequent FDA adviser,Dr Steven Nissen, agreed with the decision and said he would not have granted emergency access in the first place.
He said, "There has never been any high-quality evidence suggesting that hyrdoxychloroquine is effective for treating or preventing coronavirus infection but there is evidence of serious side effects.”
Also interestingly last Thursday, a National Institutes of Health panel of experts revised its recommendations to specifically recommend against the drug's use except in formal studies, and that had influence on the US FDA indirectly.
The latest actions by FDA and NIH send a clear signal to health professionals against prescribing the drugs for coronavirus.
A certain high profile scammer aggressively pushed the drug beginning in the first weeks of the outbreak and stunned medical professionals when he revealed he took the drug preemptively against infection.
To date no large, rigorous studies have found the drugs safe or effective for preventing or treating COVID-19. And a string of recent studies made clear they could do more harm than good.
Pasts smaller studies by so called ‘scientific researchers’ showing the efficacy of these drugs was basically scams done by unethical researchers including one by a prominent French fraudster. Thailand Medical News will be publishing a list of all these studies and the names of the researchers involved for blacklisting and for potential law suits. There are also ongoing investigations to see if any pharmaceutical companies were involved in research data manipulation especially one prominent French pharma company.
The US FDA granted emergency use of the drugs for coronavirus patients in late March at the same time the U.S. government accepted 30 million doses of hydroxychloroquine and chloroquine that had been donated by two foreign drug manufacturers. Millions of those doses were s
hipped to U.S. hospitals to treat patient who weren't enrolled in clinical trials.
However the FDA previously warned doctors that it had seen reports of dangerous side effects and heart problems reported to poison control centers and other health systems.
The regulatory agency said Monday it revoked the authorization in consultation with the Biomedical Advanced Research and Development Authority, or BARDA, which had requested the emergency use.
Interestingly, BARDA's former director said in April that he was removed from his job because he resisted political pressure to allow widespread use of the malaria drugs. Dr Rick Bright said he worked with FDA senior staff to limit the drugs' authorization to patients hospitalized with COVID-19 and under professional supervision.
Also among other issues, Dr Bright objected to the fact that some of the doses imported by the U.S. government were manufactured at facilities in India and Pakistan that had not been reviewed by the US FDA.
There are now major discussions among many law firms in the US and plaintiffs on legal and criminal proceedings and also class suits against various entities including the US FDA, The NIH, CDC, Hospitals, Doctors and members of Trump administration for promoting a lethal drug wrongly and also for advocating the usage of the drug to treat COVID-19.
At the moment three of main countries where stupid authorities are still promoting the usage of hydroxychloroquine and chloroquine for COVID-19 are Brazil, India and Pakistan.
For more on
Hydroxychloroquine, keep on logging to Thailand Medical News.
